Psychosomatic Medicine Faster Service from Outside North America
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Backstrom, T.
Right arrow Articles by Bancroft, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Backstrom, T.
Right arrow Articles by Bancroft, J.

Psychosomatic Medicine, Vol 45, Issue 6 503-507, Copyright © 1983 by American Psychosomatic Society

ORIGINAL ARTICLES

Mood, sexuality, hormones, and the menstrual cycle. II. Hormone levels and their relationship to the premenstrual syndrome

T Backstrom, D Sanders, R Leask, D Davidson, P Warner and J Bancroft

In women with premenstrual syndrome, negative changes start soon after ovulation gradually increasing as the corpus luteum develops, and reach a maximum during the last 5 days of the luteal phase. They decline rapidly once menstruation starts, disappearing within one or two days of ovarian steroids reaching baseline levels. Positive moods are at maximum when preovulatory estradiol reaches its peak. A comparison of hormone levels in women with high and low degrees of cyclical mood change showed no difference in progesterone, estradiol, testosterone, or androstenedione.


This article has been cited by other articles:


Home page
 Psychosom. Med.Home page
C. L. Weiner, M. Primeau, and D. A. Ehrmann
Androgens and Mood Dysfunction in Women: Comparison of Women With Polycystic Ovarian Syndrome to Healthy Controls
Psychosom Med, May 1, 2004; 66(3): 356 - 362.
[Abstract] [Full Text] [PDF]

Home page
 Arch Gen PsychiatryHome page
C. N. Epperson, K. Haga, G. F. Mason, E. Sellers, R. Gueorguieva, W. Zhang, E. Weiss, D. L. Rothman, and J. H. Krystal
Cortical {gamma}-Aminobutyric Acid Levels Across the Menstrual Cycle in Healthy Women and Those With Premenstrual Dysphoric Disorder: A Proton Magnetic Resonance Spectroscopy Study
Arch Gen Psychiatry, September 1, 2002; 59(9): 851 - 858.
[Abstract] [Full Text] [PDF]

Home page
 BMJHome page
K. Wyatt, P. Dimmock, P. Jones, M. Obhrai, and S. O'Brien
Efficacy of progesterone and progestogens in management of premenstrual syndrome: systematic review
BMJ, October 6, 2001; 323(7316): 776 - 776.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
L. Seippel and T. Bäckström
Luteal-Phase Estradiol Relates to Symptom Severity in Patients with Premenstrual Syndrome
J. Clin. Endocrinol. Metab., June 1, 1998; 83(6): 1988 - 1992.
[Abstract] [Full Text]

Home page
 J. Clin. Endocrinol. Metab.Home page
T.-P. Su, P. J. Schmidt, M. Danaceau, D. L. Murphy, and D. R. Rubinow
Effect of Menstrual Cycle Phase on Neuroendocrine and Behavioral Responses to the Serotonin Agonist m-Chlorophenylpiperazine in Women with Premenstrual Syndrome and Controls
J. Clin. Endocrinol. Metab., April 1, 1997; 82(4): 1220 - 1228.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1983 by the American Psychosomatic Society